Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 1.8B | 1.8B | 2.0B |
Cost of revenue | 1.3B | 1.2B | 1.2B | 1.3B |
Gross profit | 772M | 644M | 636M | 725M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 361M | 358M | 345M | 368M |
Other operating expenses | — | — | — | — |
Operating income | 411M | 286M | 291M | 357M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 26M | 26M | 24M | 25M |
Other income expense | -7M | -7M | -8M | -85M |
Pretax income | 378M | 254M | 258M | 248M |
Tax provision | 95M | 56M | 65M | 68M |
Net income | 283M | 198M | 193M | 180M |
Basic EPS | — | 0.9 | 0.9 | 0.8 |
Diluted EPS | — | 0.9 | 0.9 | 0.8 |
Basic average shares | — | 210.9M | 212.5M | 215.7M |
Diluted average shares | — | 213M | 215M | 218M |
EBITDA | 404M | 280M | 282M | 273M |
Net income from continuing op. | 344M | 262M | -83M | 309M |
Minority interests | -13M | -12M | -11M | -13M |
Preferred stock dividends | 0 | 0 | 0 | 0 |